Suppr超能文献

造血干细胞移植患儿发生肝窦阻塞综合征的遗传易感性。

Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.

机构信息

CANSEARCH Research Laboratory, Department of Pediatrics, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Pediatrics, Oncology-Hematology Unit, Geneva University Hospital, Geneva, Switzerland.

Charles-Bruneau Cancer Center, Sainte-Justine University Health Center (SJUHC), Montreal, Quebec, Canada; Department of Pharmacology and Physiology, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.

出版信息

Biol Blood Marrow Transplant. 2020 May;26(5):920-927. doi: 10.1016/j.bbmt.2019.11.026. Epub 2019 Nov 29.

Abstract

Sinusoidal obstruction syndrome (SOS) is a well-recognized and potentially life-threatening complication of hematopoietic stem cell transplantation (HSCT). SOS arises from endothelial cell damage and hepatocellular injury mostly due to the transplantation conditioning regimens but also to other patient, disease, and treatment-related factors. Understanding risk factors associated with the development of SOS is critical for early initiation of treatment or prophylaxis. The knowledge about genetic contribution is limited; few studies investigated so far selected a set of genes. To get more comprehensive insight in the genetic component, we performed an exome-wide association study using genetic variants derived from whole-exome sequencing. The analyses were performed in a discovery cohort composed of 87 pediatric patients undergoing HSCT following a busulfan-containing conditioning regimen. Eight lead single-nucleotide polymorphisms (SNPs) were identified after correction for multiple testing and subsequently analyzed in a validation cohort (n = 182). Three SNPs were successfully replicated, including rs17146905 (P = .001), rs16931326 (P = .04), and rs2289971 (P = .03), located respectively in the UGT2B10, BHLHE22, and KIAA1715 genes. UGT2B10 and KIAA1715 were retained in a multivariable model while controlling for nongenetic covariates and previously identified risk variants in the GSTA1 promoter. The modulation of associations by conditioning regimens was noted; KIAA1715 was dependent on the intensity of the conditioning regimen, whereas the effect of UGT2B10 was equally applicable to all of them. Combined effect of associated loci was also observed (P = .00006) with a genotype-related SOS risk of 9.8. To our knowledge, this is the first study addressing the genetic component of SOS at an exome-wide level and identifying novel genetic variations conferring a higher risk of SOS, which might be useful for personalized prevention and treatment strategies.

摘要

窦状隙阻塞综合征(SOS)是造血干细胞移植(HSCT)后一种公认的、潜在危及生命的并发症。SOS 主要由内皮细胞损伤和肝细胞损伤引起,主要与移植预处理方案有关,但也与其他患者、疾病和治疗相关因素有关。了解与 SOS 发展相关的危险因素对于早期开始治疗或预防至关重要。目前关于遗传因素的研究还很有限,到目前为止,只有少数研究选择了一组基因进行调查。为了更全面地了解遗传因素,我们使用全外显子测序获得的遗传变异进行了外显子组全关联研究。分析在一个由 87 名接受包含白消安预处理方案的 HSCT 的儿科患者组成的发现队列中进行。在经过多重检验校正后,确定了 8 个主要单核苷酸多态性(SNP),并在验证队列(n=182)中进行了分析。成功复制了 3 个 SNP,包括位于 UGT2B10、BHLHE22 和 KIAA1715 基因的 rs17146905(P=0.001)、rs16931326(P=0.04)和 rs2289971(P=0.03)。UGT2B10 和 KIAA1715 在多变量模型中保留,同时控制了非遗传协变量和 GSTA1 启动子中先前确定的风险变异。还注意到了与预处理方案相关的关联的调节作用;KIAA1715 依赖于预处理方案的强度,而 UGT2B10 的作用适用于所有预处理方案。还观察到相关基因座的联合效应(P=0.00006),与 SOS 相关的基因型风险为 9.8。据我们所知,这是第一项在外显子组水平上研究 SOS 的遗传成分,并确定了新的遗传变异,这些变异可能对 SOS 的个体化预防和治疗策略有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验